Measures of the DSM–5 mixed-features specifier of major depressive disorder

Publisher： Cambridge University Press

E-ISSN： 2165-6509|22|2|196-202

ISSN： 1092-8529

Source： CNS Spectrums, Vol.22, Iss.2, 2017-01, pp. : 196-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mixed features in major depressive disorder: diagnoses and treatments

By  

CNS Spectrums, Vol. 22, Iss. 2, 2017-05 ,pp. : 155-160

Cambridge University Press

Access to resources Recommend Favorite

What is the role of conventional antidepressants in the treatment of major depressive episodes with Mixed Features Specifier?

By  

CNS Spectrums, Vol. 22, Iss. 2, 2016-11 ,pp. : 120-125

Cambridge University Press

Access to resources Recommend Favorite

Exclusion of overlapping symptoms in DSM-5 mixed features specifier: heuristic diagnostic and treatment implications

By  

CNS Spectrums, Vol. 22, Iss. 2, 2016-11 ,pp. : 126-133

Cambridge University Press

Access to resources Recommend Favorite

Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis

By  

CNS Spectrums, Vol. 22, Iss. 2, 2017-03 ,pp. : 228-235

Cambridge University Press

Access to resources Recommend Favorite

Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study

By  

CNS Spectrums, Vol. 22, Iss. 2, 2017-03 ,pp. : 236-245

Cambridge University Press

Access to resources Recommend Favorite